Home MindRank to Showcase AI-Driven Drug Discovery Platform and Innovative Pipeline at BIO International Convention 2026

MindRank to Showcase AI-Driven Drug Discovery Platform and Innovative Pipeline at BIO International Convention 2026

Jun 17, 2026 17:48 CST Updated 17:48
MindRank

AI Drug Developer

June 22, 2026As of the 25th,BIO International ConventionGrandly held in San Diego, USA. As a leading AI-driven innovative enterprise in drug R&D, MindRank will attend the conference with its AI-powered drug discovery platform and self-developed innovative drug pipeline, engaging in face-to-face exchanges with biopharmaceutical companies, investment institutions, and industry partners from around the world.


Image


At this conference, MindRank will showcase:

  • The world’s first AI-designed oral small-molecule GLP-1 drug to enter Phase III clinical trials;

  • A portfolio of novel drug candidates with first-in-class or best-in-class potential, centered on the metabolic pipeline;

  • Self-developed Industrial-Grade One-Stop AI-Driven New Drug R&D Platform Engine,Covering the Entire Drug R&D Process:PharmKGTMMolecule Pro: A Knowledge Graph-Based Data Mining PlatformTMOne-Stop AI Drug Design Platform, Molecule DanceTMProtein dynamics simulation and structure prediction platform, preclinical prediction platform, and clinical prediction platform.


1

Exhibition Information

Exhibition Name


BIO International Convention 2026

Exhibition Dates


June 22–25, 2026


Exhibition Venue


San Diego Convention Center, USA

San Diego, USA


Contact Information


Search for “MindRank” via the official BIO Partnering™ system to send us a meeting invitation directly, or schedule an appointment in advance through official channels.

Email Address:bd@mindrank.ai


We look forward to meeting you in sunny San Diego and collaborating together!


Image

About the BIO International Convention

Image

The BIO International Convention, established in 1993 and organized by the Biotechnology Innovation Organization (BIO), has become one of the largest, most specialized, and influential annual biotechnology events worldwide, enjoying a prestigious reputation within the industry. The BIO Convention attracts approximately 20,000 global biotechnology professionals each year, bringing together leading pharmaceutical companies, biotech firms, investors, service providers, and other stakeholders. Through a series of professional forums, partnering sessions, and other activities, it provides a comprehensive platform for information exchange and dissemination, technological collaboration and transactions, and venture capital financing.


About MindRank

Image

MindRank is a global leader in AI-driven drug discovery, dedicated to empowering new drug development through machine learning, reinforcement learning, and first-principles calculations. Leveraging its proprietary, one-stop AI platform that deeply integrates biology, structural biology, chemistry, and medicine, MindRank pushes the boundaries of pharmaceutical technology to ensure more diseases become treatable and more lives are restored to health.

For more information, please visit the website:

www.mindrank.ai

Partnership: bd@mindrank.ai

Image

Others: info@mindrank.ai


Image

Recommended Reading


Major Breakthrough! Nature Subjournal (IF=26.8) Publishes MindRank’s AI-Driven Reconstruction of the Drug Discovery Process, Breaking Through the Treatment Challenge of Alzheimer’s Disease

MindRank’s AI-Assisted Design of Oral Small-Molecule Weight-Loss Drug MDR-001 Initiates Phase III Clinical Trials

24 Weeks, 10.3% Weight Loss! MindRank’s First AI-Designed Small-Molecule GLP-1 Receptor Agonist MDR-001 Achieves Success in Phase IIb Clinical Trial

IND Approval | MindRank’s Self-Developed Dual WEE1/YES1 Inhibitor Receives FDA Clinical Trial Authorization


Image
Image